Bessemer Group Inc Axonics, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 55 shares of AXNX stock, worth $3,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$3,903

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$67.3 - $69.67 $3,701 - $3,831	55 New	55 $4,000
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $786,340 - $823,959	-11,830 Closed	0 $0
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $761,644 - $932,198	-13,440 Reduced 53.19%	11,830 $816,000
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $312,575 - $403,537	6,330 Added 33.42%	25,270 $1.57 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $454,881 - $584,593	9,352 Added 97.54%	18,940 $1.06 Million
Q2 2023 Aug 10, 2023	BUY	$47.99 - $60.21 $460,128 - $577,293	9,588 New	9,588 $484,000
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $5,158 - $6,952	89 New	89 $6,000
Q4 2021 Jan 27, 2022	SELL	$50.01 - $73.35 $7,151 - $10,489	-143 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $8,467 - $11,248	143 New	143 $9,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account